{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:54:20Z","timestamp":1791276860253,"version":"4.1.0"},"reference-count":39,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The continuous emergence of SARS-CoV-2 variants with enhanced transmissibility and immune escape capability underscores the urgent need for mutation-independent anti-viral strategies. SARS-CoV-2 non-structural protein 12 (NSP12), which encodes the RNA-dependent RNA polymerase (RdRp), is an essential component of the viral replication complex and represents a highly conserved target for therapeutic intervention. In this study, we developed RNA aptamers, composed of 2\u2032-hydroxyl nucleotides or 2\u2032-fluoro pyrimidines, targeting NSP12 using the SELEX (Systematic Evolution of Ligands by EXponential enrichment) approach. SELEX was performed with purified NSP12 protein derived from the Omicron variant, leading to the identification of aptamer candidates with high binding ability. RNA\u2013protein pull-down assays confirmed binding between representative aptamers and NSP12 with high affinity. Competition assays supported binding specificity between aptamers and NSP12. Of note, functional evaluation using a primer extension assay revealed that the aptamers effectively inhibited NSP12 RdRp activity in vitro. Furthermore, the aptamers consistently bound to and inhibited NSP12 variants from wild-type, Alpha, Delta, and Omicron strains. These results suggest that the selected RNA aptamers are potential as broad-spectrum inhibitors targeting a conserved region of NSP12 and may serve as a promising platform for the development of anti-viral agents against current and emerging SARS-CoV-2 variants, as well as other RNA viruses.<\/jats:p>","DOI":"10.3390\/ijms262211177","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:55:31Z","timestamp":1763556931000},"page":"11177","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro"],"prefix":"10.3390","volume":"26","author":[{"given":"Chaewon","family":"Song","sequence":"first","affiliation":[{"name":"Department of Bioconvergence Engineering, Research Institute of Advanced Omics, Dankook University, Yongin 16890, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1718-7601","authenticated-orcid":false,"given":"Seong-Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Bioconvergence Engineering, Research Institute of Advanced Omics, Dankook University, Yongin 16890, Republic of Korea"},{"name":"R&D Center, Rznomics Inc., Seongnam 13486, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health\u2014The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_2","unstructured":"(2025, July 15). Statement on the Fifteenth Meeting of the IHR. Emergency Committee on the COVID-19 Pandemic. Available online: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Brant, A.C., Tian, W., Majerciak, V., Yang, W., and Zheng, Z.-M. (2021). SARS-CoV-2: From Its Discovery to Genome Structure, Transcription, and Replication. Cell Biosci., 11.","DOI":"10.1186\/s13578-021-00643-z"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Romano, M., Ruggiero, A., Squeglia, F., Maga, G., and Berisio, R. (2020). A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells, 9.","DOI":"10.20944\/preprints202004.0510.v1"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"O\u2019Leary, V.B., Dolly, O.J., H\u00f6schl, C., \u010cerna, M., and Ovsepian, S.V. (2021). Unpacking Pandora from Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010386"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107774","DOI":"10.1016\/j.celrep.2020.107774","article-title":"Structural and Biochemical Characterization of the Nsp12-Nsp7-Nsp8 Core Polymerase Complex from SARS-CoV-2","volume":"31","author":"Peng","year":"2020","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0508200103","article-title":"Discovery of an RNA Virus 3\u2032\u21925\u2032 Exoribonuclease That Is Critically Involved in Coronavirus RNA Synthesis","volume":"103","author":"Minskaia","year":"2006","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/rna.8.2.15013","article-title":"Coronaviruses: An RNA Proofreading Machine Regulates Replication Fidelity and Diversity","volume":"8","author":"Denison","year":"2011","journal-title":"RNA Biol."},{"key":"ref_10","unstructured":"(2025, July 16). Tracking SARS-CoV-2 Variants. Available online: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 Mutation Hot Spots Include a Novel RNA-Dependent-RNA Polymerase Variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Goldswain, H., Dong, X., Penrice-Randal, R., Alruwaili, M., Shawli, G.T., Prince, T., Williamson, M.K., Raghwani, J., Randle, N., and Jones, B. (2023). The P323L Substitution in the SARS-CoV-2 Polymerase (NSP12) Confers a Selective Advantage during Infection. Genome Biol., 24.","DOI":"10.1186\/s13059-023-02881-5"},{"key":"ref_14","unstructured":"(2025, July 17). SARS-CoV-2 Variants\u2014Omicron BA.2\u2014Stanford Coronavirus Antiviral & Resistance Database (CoVDB). Available online: https:\/\/covdb.stanford.edu\/variants\/omicron_xbb\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113077","DOI":"10.1016\/j.celrep.2023.113077","article-title":"SARS-CoV-2 Variants with NSP12 P323L\/G671S Mutations Display Enhanced Virus Replication in Ferret Upper Airways and Higher Transmissibility","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In Vitro Selection of RNA Molecules That Bind Specific Ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kim, T.-H., and Lee, S.-W. (2021). Aptamers for Anti-Viral Therapeutics and Diagnostics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084168"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.3390\/s150716281","article-title":"Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing","volume":"15","author":"Ku","year":"2015","journal-title":"Sensors"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bioeng.2007.06.001","article-title":"SELEX\u2014A (r)Evolutionary Method to Generate High-Affinity Nucleic Acid Ligands","volume":"24","author":"Stoltenburg","year":"2007","journal-title":"Biomol. Eng."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"0076","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of Aptamer Discovery and Technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2112942118","DOI":"10.1073\/pnas.2112942118","article-title":"A Serum-Stable RNA Aptamer Specific for SARS-CoV-2 Neutralizes Viral Entry","volume":"118","author":"Valero","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b906788d","article-title":"RNA Aptamer-Based Sensitive Detection of SARS Coronavirus Nucleocapsid Protein","volume":"134","author":"Ahn","year":"2009","journal-title":"Analyst"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126264","DOI":"10.1016\/j.talanta.2024.126264","article-title":"Rapid One-Pot Isothermal Amplification Reassembled of Fluorescent RNA Aptamer for SARS-CoV-2 Detection","volume":"276","author":"Peng","year":"2024","journal-title":"Talanta"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Shekar, P.V., Kumar, A., Mulgaonkar, N., Kashyap, S., Choudhir, G., Fernando, S., and Rustgi, S. (2025). Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. Biomolecules, 15.","DOI":"10.3390\/biom15060805"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41589-025-01868-6","article-title":"Single-Step Discovery of High-Affinity RNA Ligands by UltraSelex","volume":"21","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1042\/BCJ20210200","article-title":"Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp12\/7\/8 RNA-Dependent RNA Polymerase","volume":"478","author":"Bertolin","year":"2021","journal-title":"Biochem. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ilmj\u00e4rv, S., Abdul, F., Acosta-Guti\u00e9rrez, S., Estarellas, C., Galdadas, I., Casimir, M., Alessandrini, M., Gervasio, F.L., and Krause, K.-H. (2021). Concurrent Mutations in RNA-Dependent RNA Polymerase and Spike Protein Emerged as the Epidemiologically Most Successful SARS-CoV-2 Variant. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-91662-w"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Suratekar, R., Ghosh, P., Niesen, M.J.M., Donadio, G., Anand, P., Soundararajan, V., and Venkatakrishnan, A.J. (2022). High Diversity in Delta Variant across Countries Revealed by Genome-wide Analysis of SARS-CoV-2 beyond the Spike Protein. Mol. Syst. Biol., 18.","DOI":"10.15252\/msb.202110673"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Abbasian, M.H., Rahimian, K., Mahmanzar, M., Bayat, S., Kuehu, D.L., Sisakht, M.M., Moradi, B., and Deng, Y. (2024). Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends. Viruses, 16.","DOI":"10.3390\/v16081331"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e5103","DOI":"10.1002\/pro.5103","article-title":"Biochemical Characterization of Naturally Occurring Mutations in SARS-CoV-2 RNA-Dependent RNA Polymerase","volume":"33","author":"Danda","year":"2024","journal-title":"Protein Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De Novo Emergence of a Remdesivir Resistance Mutation during Treatment of Persistent SARS-CoV-2 Infection in an Immunocompromised Patient: A Case Report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40588-024-00229-6","article-title":"SARS-CoV-2 Resistance to Small Molecule Inhibitors","volume":"11","author":"Lopez","year":"2024","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"pgaf085","DOI":"10.1093\/pnasnexus\/pgaf085","article-title":"Clinical and Molecular Landscape of Prolonged SARS-CoV-2 Infection with Resistance to Remdesivir in Immunocompromised Patients","volume":"4","author":"Iriyama","year":"2025","journal-title":"PNAS Nexus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s11671-025-04245-3","article-title":"Aptamer-Engaged Nanotherapeutics against SARS-CoV-2","volume":"20","author":"Zhang","year":"2025","journal-title":"Discov. Nano."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e12024","DOI":"10.1002\/bmm2.12024","article-title":"Aptamer-Based Strategies against SARS-CoV-2 Viruses","volume":"1","author":"Huang","year":"2023","journal-title":"BMEMat"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2017.0680","article-title":"Effect of Chemical Modifications on Aptamer Stability in Serum","volume":"27","author":"Kratschmer","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1261\/rna.5239604","article-title":"In Vivo Activity of Nuclease-Resistant siRNAs","volume":"10","author":"Layzer","year":"2004","journal-title":"RNA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of Replicating SARS-CoV-2 Polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11177\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:55:46Z","timestamp":1763556946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":39,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262211177"],"URL":"https:\/\/doi.org\/10.3390\/ijms262211177","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}